Cost effectiveness in treating ventilator-associated pneumonia

AUTOR(ES)

Niederman, Michael S

FONTE

BioMed Central

RESUMO

Ventilator-associated pneumonia is a common illness in intensive care unit patients. The costs of management are increased when infection involves resistant organisms, as well as unnecessary and prolonged therapy. Efforts at accurate diagnosis, therapy and prevention can reduce the cost impact of this illness.

Documentos Relacionados

• Ventilator-associated pneumonia and oral health
• The effectiveness of a bundle in the prevention of ventilator-associated pneumonia
• Prior oropharyngeal colonization and ventilator-associated pneumonia
• The paradox of ventilator-associated pneumonia prevention measures
• Copeptin, a novel prognostic biomarker in ventilator-associated pneumonia